Cardiovascular disease, type 2 diabetes, certain cancers, liver disease, kidney disease, joint destruction, and reduced life expectancy all link directly to excess body weight
Clinical effectiveness and safety of once-weekly GLP-1 receptor agonist dulaglutide as add-on to metformin or metformin plus insulin secretagogues in obesity and type 2 diabetes
The overall benefit of metabolic-targeted therapies for MASLD is appealing, as these agents might also reduce other cardiometabolic risk factors that contribute to cardiovascular disease, which is the leading cause of death in patients with MASLD
We can prescribe you semaglutide in Coeur dAlene
At our telehealth clinic, we work with various microdosing protocols for semaglutide and other peptide therapies, and were with you the whole way through
We have won the praise and trust of customers with high-quality goods, reasonable prices and good service